Biotech Values

[biotech2020]

I think partnering would be helpful for near term price support, but Revance has significant upside regardless of whether they partner or go it alone. The real advantage they have is a best in class product in a fast growing market. They have enough cash to get through approval, and I don't think significant dilution would be required for commercialization. They shouldn't need a large sales force for the aesthetic market if they get the 6 month label. I took advantage of the recent selloff to add to my already oversized position.